With the FSSAI suspending licenses across six nutraceutical manufacturers over poor hygiene, expired materials, and unapproved ingredients—and issuing a fresh show-cause notice to Red Bull over its "energy drink" label—the compliance net is tightening fast. Between September 1 and November 5 alone, 56,431 food establishments were inspected nationwide.
For far too long, a segment of the market treated FSSAI licensing as a low-barrier shortcut to bypass stringent CDSCO drug standards while making aggressive clinical claims. That playbook is now a liability.
In the latest MedicinMan Intelligence Report (MIR), I examine what this regulatory reckoning means for India's nutraceutical ecosystem:




